Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024

BUY
$69.43 - $83.43 $157,536 - $189,302
2,269 New
2,269 $186,000
Q3 2022

Nov 01, 2022

SELL
$80.75 - $95.31 $239,020 - $282,117
-2,960 Reduced 36.93%
5,056 $408,000
Q2 2022

Jul 28, 2022

SELL
$87.4 - $113.09 $41,952 - $54,283
-480 Reduced 5.65%
8,016 $719,000
Q1 2022

Apr 21, 2022

SELL
$100.58 - $112.38 $231,334 - $258,474
-2,300 Reduced 21.3%
8,496 $936,000
Q4 2021

Jan 24, 2022

SELL
$99.53 - $127.75 $62,007 - $79,588
-623 Reduced 5.46%
10,796 $1.12 Million
Q3 2021

Nov 01, 2021

SELL
$122.75 - $135.17 $14,607 - $16,085
-119 Reduced 1.03%
11,419 $1.43 Million
Q2 2021

Jul 12, 2021

SELL
$118.19 - $131.5 $17,492 - $19,462
-148 Reduced 1.27%
11,538 $1.43 Million
Q1 2021

Apr 28, 2021

BUY
$111.18 - $119.74 $98,283 - $105,850
884 Added 8.18%
11,686 $1.38 Million
Q4 2020

Jan 28, 2021

SELL
$100.57 - $117.14 $5,933 - $6,911
-59 Reduced 0.54%
10,802 $1.27 Million
Q3 2020

Oct 19, 2020

SELL
$90.13 - $108.78 $24,605 - $29,696
-273 Reduced 2.45%
10,861 $1.13 Million
Q2 2020

Jul 27, 2020

BUY
$84.11 - $103.33 $63,082 - $77,497
750 Added 7.22%
11,134 $1.02 Million
Q1 2020

Apr 30, 2020

BUY
$72.92 - $121.3 $67,451 - $112,202
925 Added 9.78%
10,384 $936,000
Q4 2019

Feb 06, 2020

BUY
$104.49 - $114.54 $28,734 - $31,498
275 Added 2.99%
9,459 $1.07 Million
Q3 2019

Oct 28, 2019

SELL
$98.02 - $111.18 $22,054 - $25,015
-225 Reduced 2.39%
9,184 $998,000
Q2 2019

Aug 08, 2019

BUY
$84.15 - $99.38 $15,062 - $17,789
179 Added 1.94%
9,409 $916,000
Q1 2019

May 13, 2019

BUY
$82.45 - $93.79 $2,638 - $3,001
32 Added 0.35%
9,230 $841,000
Q4 2018

Feb 14, 2019

BUY
$85.8 - $99.49 $789,188 - $915,109
9,198 New
9,198 $837,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $121B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Dagco, Inc. Portfolio

Follow Dagco, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dagco, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dagco, Inc. with notifications on news.